Abstract
Positron emission tomography (PET) has transformed medical imaging, and while first developed and applied to the human setting, it has found widespread application at the preclinical level over the past two decades. Its strength is that it offers noninvasive 3D tomographic imaging in a quantitative manner at very high sensitivity. Paired with the right molecular probes, invaluable insights into physiology and pathophysiology have been accessible and therapeutic development has been enhanced through preclinical PET imaging. PET imaging is now often routinely combined with either computed tomography (CT) or magnetic resonance imaging (MRI) to provide additional anatomical context. All these developments were accompanied by the provision of ever more complex and powerful analysis software enabling users to visualize and quantify signals from PET imaging data. Aside from experimental complexities, there are also various pitfalls in PET image data analysis, which can negatively impact on reporting and reproducibility.
Here, we provide a protocol intended to guide the inexperienced user through PET/CT data analysis. We describe the general principles and workflows required for PET/CT image data visualization and quantitative analysis using various software packages popular in the field. Moreover, we present recommendations for reporting of preclinical PET/CT data including examples of good and poor practice.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mankoff DA, Farwell MD, Clark AS, Pryma DA (2017) Making molecular imaging a clinical tool for precision oncology: a review. JAMA Oncol 3(5):695–701. https://doi.org/10.1001/jamaoncol.2016.5084
Schwartz LH, Litiere S, de Vries E, Ford R, Gwyther S, Mandrekar S, Shankar L, Bogaerts J, Chen A, Dancey J, Hayes W, Hodi FS, Hoekstra OS, Huang EP, Lin N, Liu Y, Therasse P, Wolchok JD, Seymour L (2016) RECIST 1.1-Update and clarification: from the RECIST committee. Eur J Cancer 62:132–137. https://doi.org/10.1016/j.ejca.2016.03.081
Seymour L, Bogaerts J, Perrone A, Ford R, Schwartz LH, Mandrekar S, Lin NU, Litiere S, Dancey J, Chen A, Hodi FS, Therasse P, Hoekstra OS, Shankar LK, Wolchok JD, Ballinger M, Caramella C, de Vries EGE, group Rw (2017) iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics. Lancet Oncol 18(3):e143–e152. https://doi.org/10.1016/S1470-2045(17)30074-8
Kircher MF, Hricak H, Larson SM (2012) Molecular imaging for personalized cancer care. Mol Oncol 6(2):182–195. https://doi.org/10.1016/j.molonc.2012.02.005
Krekorian M, Fruhwirth GO, Srinivas M, Figdor CG, Heskamp S, Witney TH, Aarntzen E (2019) Imaging of T-cells and their responses during anti-cancer immunotherapy. Theranostics 9(25):7924–7947. https://doi.org/10.7150/thno.37924
Beaurain M, Salabert AS, Ribeiro MJ, Arlicot N, Damier P, Le Jeune F, Demonet JF, Payoux P (2019) Innovative molecular imaging for clinical research, therapeutic stratification, and nosography in neuroscience. Front Med (Lausanne) 6:268. https://doi.org/10.3389/fmed.2019.00268
Kreisl WC, Kim MJ, Coughlin JM, Henter ID, Owen DR, Innis RB (2020) PET imaging of neuroinflammation in neurological disorders. Lancet Neurol 19(11):940–950. https://doi.org/10.1016/S1474-4422(20)30346-X
Henriksen G, Drzezga A (2011) Imaging in neurology research II: PET imaging of CNS disorders. In: Kiessling F, Pichler BJ (eds) Small animal imaging: basics and practical guide. Springer, Berlin, Heidelberg, pp 499–513. https://doi.org/10.1007/978-3-642-12945-2_33
Schiffer WK (2011) Imaging in neurology research III: focus on neurotransmitter imaging. In: Kiessling F, Pichler BJ (eds) Small animal imaging: basics and practical guide. Springer, Berlin Heidelberg, pp 515–541. https://doi.org/10.1007/978-3-642-12945-2_34
Chen IY, Wu JC (2011) Cardiovascular molecular imaging: focus on clinical translation. Circulation 123(4):425–443. https://doi.org/10.1161/CIRCULATIONAHA.109.916338
Bengel FM (2005) Noninvasive imaging of cardiac gene expression and its future implications for molecular therapy. Mol Imaging Biol 7(1):22–29. https://doi.org/10.1007/s11307-005-0923-1
Farber G, Boczar KE, Wiefels CC, Zelt JGE, Guler EC, deKemp RA, Beanlands RS, Rotstein BH (2020) The future of cardiac molecular imaging. Semin Nucl Med 50(4):367–385. https://doi.org/10.1053/j.semnuclmed.2020.02.005
McCarthy CE, White JM, Viola NT, Gibson HM (2020) In vivo imaging technologies to monitor the immune system. Front Immunol 11:1067. https://doi.org/10.3389/fimmu.2020.01067
Signore A, Anzola KL, Auletta S, Varani M, Petitti A, Pacilio M, Galli F, Lauri C (2018) Current status of molecular imaging in inflammatory and autoimmune disorders. Curr Pharm Des 24(7):743–753. https://doi.org/10.2174/1381612824666180130115153
Lee JT, Nair-Gill ED, Rabinovich BA, Radu CG, Witte ON (2011) Imaging in immunology research. In: Kiessling F, Pichler BJ (eds) Small animal imaging: basics and practical guide. Springer, Berlin Heidelberg, pp 565–583. https://doi.org/10.1007/978-3-642-12945-2_36
Mankoff DA (2007) A definition of molecular imaging. J Nucl Med 48(6):18N, 21N
Iafrate M, Fruhwirth GO (2020) How non-invasive in vivo cell tracking supports the development and translation of cancer immunotherapies. Front Physiol 11(154). https://doi.org/10.3389/fphys.2020.00154
Diocou S, Volpe A, Jauregui-Osoro M, Boudjemeline M, Chuamsaamarkkee K, Man F, Blower PJ, Ng T, Mullen GED, Fruhwirth GO (2017) [(18)F]tetrafluoroborate-PET/CT enables sensitive tumor and metastasis in vivo imaging in a sodium iodide symporter-expressing tumor model. Sci Rep 7(1):946. https://doi.org/10.1038/s41598-017-01044-4
Maiques O, Fanshawe B, Crosas-Molist E, Rodriguez-Hernandez I, Volpe A, Cantelli G, Boehme L, Orgaz JL, Mardakheh FK, Sanz-Moreno V, Fruhwirth GO (2021) A preclinical pipeline to evaluate migrastatics as therapeutic agents in metastatic melanoma. Br J Cancer 125(5):699–713. https://doi.org/10.1038/s41416-021-01442-6
Merron A, Peerlinck I, Martin-Duque P, Burnet J, Quintanilla M, Mather S, Hingorani M, Harrington K, Iggo R, Vassaux G (2007) SPECT/CT imaging of oncolytic adenovirus propagation in tumours in vivo using the Na/I symporter as a reporter gene. Gene Ther 14(24):1731–1738. https://doi.org/10.1038/sj.gt.3303043
Ashmore-Harris C, Blackford SJ, Grimsdell B, Kurtys E, Glatz MC, Rashid TS, Fruhwirth GO (2019) Reporter gene-engineering of human induced pluripotent stem cells during differentiation renders in vivo traceable hepatocyte-like cells accessible. Stem Cell Res 41:101599. https://doi.org/10.1016/j.scr.2019.101599
Terrovitis J, Kwok KF, Lautamaki R, Engles JM, Barth AS, Kizana E, Miake J, Leppo MK, Fox J, Seidel J, Pomper M, Wahl RL, Tsui B, Bengel F, Marban E, Abraham MR (2008) Ectopic expression of the sodium-iodide symporter enables imaging of transplanted cardiac stem cells in vivo by single-photon emission computed tomography or positron emission tomography. J Am Coll Cardiol 52(20):1652–1660. https://doi.org/10.1016/j.jacc.2008.06.051
Hung SC, Deng WP, Yang WK, Liu RS, Lee CC, Su TC, Lin RJ, Yang DM, Chang CW, Chen WH, Wei HJ, Gelovani JG (2005) Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging. Clin Cancer Res 11(21):7749–7756. https://doi.org/10.1158/1078-0432.CCR-05-0876
Ashmore-Harris C, Iafrate M, Saleem A, Fruhwirth GO (2020) Non-invasive reporter gene imaging of cell therapies, including T cells and stem cells. Mol Ther 28(6):1392–1416. https://doi.org/10.1016/j.ymthe.2020.03.016
Minn I, Huss DJ, Ahn HH, Chinn TM, Park A, Jones J, Brummet M, Rowe SP, Sysa-Shah P, Du Y, Levitsky HI, Pomper MG (2019) Imaging CAR T cell therapy with PSMA-targeted positron emission tomography. Sci Adv 5 (7):eaaw5096. https://doi.org/10.1126/sciadv.aaw5096
Volpe A, Lang C, Lim L, Man F, Kurtys E, Ashmore-Harris C, Johnson P, Skourti E, de Rosales RTM, Fruhwirth GO (2020) Spatiotemporal PET imaging reveals differences in CAR-T tumor retention in triple-negative breast cancer models. Mol Ther 28(10):2271–2285. https://doi.org/10.1016/j.ymthe.2020.06.028
Jacob J, Nadkarni S, Volpe A, Peng Q, Tung SL, Hannen RF, Mohseni YR, Scotta C, Marelli-Berg FM, Lechler RI, Smyth LA, Fruhwirth GO, Lombardi G (2021) Spatiotemporal in vivo tracking of polyclonal human regulatory T cells (Tregs) reveals a role for innate immune cells in Treg transplant recruitment. Mol Ther Methods Clin Dev 20:324–336. https://doi.org/10.1016/j.omtm.2020.12.003
Keu KV, Witney TH, Yaghoubi S, Rosenberg J, Kurien A, Magnusson R, Williams J, Habte F, Wagner JR, Forman S, Brown C, Allen-Auerbach M, Czernin J, Tang W, Jensen MC, Badie B, Gambhir SS (2017) Reporter gene imaging of targeted T cell immunotherapy in recurrent glioma. Sci Transl Med 9(373). https://doi.org/10.1126/scitranslmed.aag2196
Weist MR, Starr R, Aguilar B, Chea J, Miles JK, Poku E, Gerdts E, Yang X, Priceman SJ, Forman SJ, Colcher D, Brown CE, Shively JE (2018) PET of adoptively transferred Chimeric antigen receptor T cells with (89)Zr-Oxine. J Nucl Med 59(10):1531–1537. https://doi.org/10.2967/jnumed.117.206714
Man F, Lim L, Volpe A, Gabizon A, Shmeeda H, Draper B, Parente-Pereira AC, Maher J, Blower PJ, Fruhwirth GO, R TMdR (2019) In vivo PET tracking of (89)Zr-labeled Vgamma9Vdelta2 T cells to Mouse Xenograft breast tumors activated with liposomal alendronate. Mol Ther 27(1):219–229. https://doi.org/10.1016/j.ymthe.2018.10.006
Jacob J, Volpe A, Peng Q, Lechler RI, Smyth LA, Lombardi G, Fruhwirth GO. Radiolabelling of Polyclonally Expanded Human Regulatory T Cells (Treg) with 89Zr-oxine for Medium-Term In Vivo Cell Tracking Molecules 2023; 28:1482 https://doi.org/10.3390/molecules28031482
Huang SC (2000) Anatomy of SUV. Standardized uptake value. Nucl Med Biol 27(7):643–646. https://doi.org/10.1016/s0969-8051(00)00155-4
McCluskey SP, Plisson C, Rabiner EA, Howes O (2020) Advances in CNS PET: the state-of-the-art for new imaging targets for pathophysiology and drug development. Eur J Nucl Med Mol Imaging 47(2):451–489. https://doi.org/10.1007/s00259-019-04488-0
McDougald W, Vanhove C, Lehnert A, Lewellen B, Wright J, Mingarelli M, Corral CA, Schneider JE, Plein S, Newby DE, Welch A, Miyaoka R, Vandenberghe S, Tavares AAS (2020) Standardization of preclinical PET/CT imaging to improve quantitative accuracy, precision, and reproducibility: a multicenter study. J Nucl Med 61(3):461–468. https://doi.org/10.2967/jnumed.119.231308
Mannheim JG, Mamach M, Reder S, Traxl A, Mucha N, Disselhorst JA, Mittelhauser M, Kuntner C, Thackeray JT, Ziegler S, Wanek T, Bankstahl JP, Pichler BJ (2019) Reproducibility and comparability of preclinical PET imaging data: a multicenter small-animal PET study. J Nucl Med 60(10):1483–1491. https://doi.org/10.2967/jnumed.118.221994
Loening AM, Gambhir SS (2003) AMIDE: a free software tool for multimodality medical image analysis. Mol Imaging 2(3):131–137. https://doi.org/10.1162/153535003322556877
Cromey DW (2010) Avoiding twisted pixels: ethical guidelines for the appropriate use and manipulation of scientific digital images. Sci Eng Ethics 16(4):639–667. https://doi.org/10.1007/s11948-010-9201-y
Otsu N (1979) A threshold selection method from gray-level histograms. IEEE Trans Syst Man Cybern 9(1):62–66. https://doi.org/10.1109/tsmc.1979.4310076
Rossner M, Yamada KM (2004) What's in a picture? The temptation of image manipulation. J Cell Biol 166(1):11–15. https://doi.org/10.1083/jcb.200406019
Mirrione MM, Ruth N, Alexoff D, Logan J, Fowler J, Kernan M (2014) Positron Emission Tomography (PET) and graphical kinetic data analysis of the Dopamine neurotransmitter system: an exercise for an undergraduate laboratory course. J Undergrad Neurosci Educ 12(2):A114–A122
Soret M, Bacharach SL, Buvat I (2007) Partial-volume effect in PET tumor imaging. J Nucl Med 48(6):932–945. https://doi.org/10.2967/jnumed.106.035774
Crameri F, Shephard GE, Heron PJ (2020) The misuse of colour in science communication. Nat Commun 11(1):5444. https://doi.org/10.1038/s41467-020-19160-7
Edmonds S, Volpe A, Shmeeda H, Parente-Pereira AC, Radia R, Baguna-Torres J, Szanda I, Severin GW, Livieratos L, Blower PJ, Maher J, Fruhwirth GO, Gabizon A, R TMdR (2016) Exploiting the metal-chelating properties of the drug Cargo for in vivo positron emission tomography imaging of liposomal nanomedicines. ACS Nano 10(11):10294–10307. https://doi.org/10.1021/acsnano.6b05935
Acknowledgments
This work was supported by the Cancer Research UK grant to GOF [C48390/A21153], the National Institute for Health Research (NIHR) Biomedical Research Centre at Guy’s and St Thomas’ NHS Foundation Trust and King’s College London, and the Wellcome/EPSRC Centre for Medical Engineering at King’s College London [WT 203148/Z/16/Z]. AV is supported by The Center for Experimental Immuno-Oncology Fellowship Award (FP00001443), the Tow Foundation Fellowship Award (FP000004141) and the Fiona and Stanley Druckenmiller Center for Lung Cancer Research Fellowship Award (FP00005072) at Memorial Sloan Kettering Cancer Center. Further support was received by an NIH/NCI Cancer Center Support Grant to MSKCC (P30 CA008748). Views expressed are those of the authors and not necessarily those of the NIHR or NHS.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Cawthorne, C.J., Volpe, A., Fruhwirth, G.O. (2024). The Basics of Visualizing, Analyzing, and Reporting Preclinical PET/CT Imaging Data. In: Witney, T.H., Shuhendler, A.J. (eds) Positron Emission Tomography. Methods in Molecular Biology, vol 2729. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3499-8_12
Download citation
DOI: https://doi.org/10.1007/978-1-0716-3499-8_12
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-3498-1
Online ISBN: 978-1-0716-3499-8
eBook Packages: Springer Protocols